Your browser doesn't support javascript.
loading
Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis.
Horton, Rachel H; Dunlop, Malcolm G; Houlston, Richard S; Lucassen, Anneke; McCartney, Margaret; McNeill, Alan; Sud, Amit.
Afiliação
  • Horton RH; Clinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Dunlop MG; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Houlston RS; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Lucassen A; Centre for Personalised Medicine, University of Oxford, Oxford, UK.
  • McCartney M; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • McNeill A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Sud A; Clinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK.
Br J Cancer ; 128(1): 1-2, 2023 01.
Article em En | MEDLINE | ID: mdl-36443602
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Sobrediagnóstico Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Sobrediagnóstico Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article